Healthcare -
Biotechnology - NASDAQ - US
$ 6.74
2.43 %
$ 686 M
Market Cap
-14.98
P/E
TRVI - OPERATING EXPENSES
Operating Expenses TRVI - Trevi Therapeutics, Inc.
51.5 M
LAST VALUE
31.26%
2 YEAR CAGR
14.10%
5 YEAR CAGR
0.00%
10 YEAR CAGR